Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Tesla Motors Q3 Loss Widens - Quick Facts

RELATED NEWS
Trade TSLA now with 

Tesla Motors, Inc. (TSLA: Quote) released its third quarter 2012 financial results. Net loss widened to $110.80 million from $65.08 million last year. Net loss per share was $1.05 compared to a loss of $0.63 prior year. Total revenues decreased to $50.10 million from $57.67 million last year.

Adjusted net loss per share was $0.92 for the quarter. Analysts polled by Thomson Reuters expected the company to report a loss of $0.90 per share on revenue of $48.29 million for the quarter. Analysts' estimates typically exclude special items.

The company said gross margin was negative 17%, in line with previous guidance, primarily because the cost of automotive sales reflects the full burden of operating Tesla factory allocated over a limited number of vehicles produced, along with launch-related variable cost inefficiencies.

The company maintained its 2012 revenue guidance of $400 million-$440 million. Towards the end of the quarter, the company expect to achieve positive free cash flow in spite of short term cost inefficiencies.

Click here to receive FREE breaking news email alerts for Tesla Motors, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.